Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
28.12
+0.01 (0.05%)
At close: Jul 15, 2026, 4:00 PM EDT
28.53
+0.42 (1.48%)
After-hours: Jul 15, 2026, 7:11 PM EDT
Bicara Therapeutics Employees
Bicara Therapeutics had 103 employees as of December 31, 2025. The number of employees increased by 48 or 87.27% compared to the previous year.
Employees
103
Change (1Y)
48
Growth (1Y)
87.27%
Revenue / Employee
n/a
Profits / Employee
-$1,527,330
Market Cap
1.85B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 48 | 87.27% |
| Dec 31, 2024 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Recursion Pharmaceuticals | 600 |
| UroGen Pharma | 298 |
| Zymeworks | 243 |
| Monte Rosa Therapeutics | 187 |
| Stoke Therapeutics | 170 |
| Precigen | 160 |
| AnaptysBio | 104 |
BCAX News
- 13 days ago - Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Bicara Therapeutics Transcript: Study update - Transcripts
- 7 weeks ago - Bicara Therapeutics Press release: Study update - Filings
- 7 weeks ago - Bicara Therapeutics Slides: Study update - Filings
- 7 weeks ago - Bicara Therapeutics management to meet with Cantor - TheFly
- 7 weeks ago - Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC - GlobeNewsWire
- 2 months ago - Bicara Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire